25.12.2013 Aufrufe

Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

MEHR ANZEIGEN
WENIGER ANZEIGEN

Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.

YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.

Literaturverzeichnis<br />

Vanderstraeten, B., Reynaert, N., Paelinck, L., Madani, I., De Wagter, C., De Gersem, W., De Neve, W., and<br />

Thierens, H. (2006). Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo,<br />

convolution/superposition, and pencil beam computations. Med Phys 33, 3149-3158.<br />

Vardiman, J.W. (2010). The World Health Organization (WHO) classification of tumors of the hematopoietic<br />

and lymphoid tissues: An overview with emphasis on the myeloid neoplasms. Chemico-Biological Interactions<br />

184, 16-20.<br />

Verhaegen, F., and Seuntjens, J. (2003). Monte Carlo modelling of external radiotherapy photon beams. Phys<br />

Med Biol 48, R107-164.<br />

Viviani, S., Bonadonna, G., Santoro, A., Bonfante, V., Zanini, M., Devizzi, L., Soncini, F., and Valagussa, P.<br />

(1996). Alternating versus hybrid MOPP and ABVD combinations in advanced <strong>Hodgkin</strong>'s disease: ten-year<br />

results. J Clin Oncol 14, 1421-1430.<br />

von der Weid, N.X. (2008). Adult life after surviving lymphoma in childhood. Support Care Cancer 16, 339-345.<br />

von Tresckow, B., Plutschow, A., Fuchs, M., Klimm, B., Markova, J., Lohri, A., Kral, Z., Greil, R., Topp, M.S.,<br />

Meissner, J., Zijlstra, J.M., Soekler, M., Stein, H., Eich, H.T., Mueller, R.P., Diehl, V., Borchmann, P., and<br />

Engert, A. (2012). Dose-Intensification in Early Unfavorable <strong>Hodgkin</strong>'s Lymphoma: Final Analysis of the<br />

German <strong>Hodgkin</strong> Study Group HD14 Trial. J Clin Oncol 30, 907-913.<br />

Weber, D.C., Johanson, S., Peguret, N., Cozzi, L., and Olsen, D.R. (2011). Predicted risk of radiation-induced<br />

cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage<br />

hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys 81, 490-497.<br />

Weber, D.C., Peguret, N., Dipasquale, G., and Cozzi, L. (2009). Involved-node and involved-field volumetric<br />

modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supradiaphragmatic<br />

<strong>Hodgkin</strong> lymphoma: a comparative planning study. Int J Radiat Oncol Biol Phys 75, 1578-1586.<br />

Weihrauch, M.R., Re, D., Scheidhauer, K., Ansen, S., Dietlein, M., Bischoff, S., Bohlen, H., Wolf, J., Schicha,<br />

H., Diehl, V., and Tesch, H. (2001). Thoracic positron emission tomography using 18F-fluorodeoxyglucose for<br />

the evaluation of residual mediastinal <strong>Hodgkin</strong> disease. Blood 98, 2930-2934.<br />

Weiner, M.A., Leventhal, B., Brecher, M.L., Marcus, R.B., Cantor, A., Gieser, P.W., Ternberg, J.L., Behm,<br />

F.G., Wharam, M.D., Jr., and Chauvenet, A.R. (1997). Randomized study of intensive MOPP-ABVD with or<br />

without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV <strong>Hodgkin</strong>'s<br />

disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 15, 2769-2779.<br />

Weiss, L.M., MacLennan, K.A., Chan, J.K.C., and Warnke, R.A. (1999). Pathology of classical <strong>Hodgkin</strong>'s<br />

disease. In <strong>Hodgkin</strong>'s disease, P.M. Mauch, J.O. Armitage, V. Diehl, R.T. Hoppe, and L.M. Weiss, eds.<br />

(Philadelphia: Lippencott Williams & Wilkins), pp. 101-120.<br />

Wertz, H., Jahnke, L., Schneider, F., Polednik, M., Fleckenstein, J., Lohr, F., and Wenz, F. (2011). A novel<br />

lateral disequilibrium inclusive (LDI) pencil-beam based dose calculation algorithm: evaluation in<br />

inhomogeneous phantoms and comparison with Monte Carlo calculations. Med Phys 38, 1627-1634.<br />

Wilks, S. (1865). Cases of enlargement of the lymphatic glands and spleen (or <strong>Hodgkin</strong>'s disease), with remarks.<br />

Guys Hosp Rep 11, 65-67.<br />

Willner, J., Jost, A., Baier, K., and Flentje, M. (2003). A little to a lot or a lot to a little? An analysis of<br />

pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-<br />

D conformal radiotherapy. Strahlenther Onkol 179, 548-556.<br />

Wu, Q., and Mohan, R. (2002). Multiple local minima in IMRT optimization based on dose-volume criteria.<br />

Med Phys 29, 1514-1527.<br />

Wu, Q., Mohan, R., Niemierko, A., and Schmidt-Ullrich, R. (2002). Optimization of intensity-modulated<br />

radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52, 224-235.<br />

Yahalom, J., and Mauch, P. (2002). The involved field is back: issues in delineating the radiation field in<br />

<strong>Hodgkin</strong>'s disease. Ann Oncol 13 Suppl 1, 79-83.<br />

Zebrack, B.J., Zeltzer, L.K., Whitton, J., Mertens, A.C., Odom, L., Berkow, R., and Robison, L.L. (2002).<br />

Psychological outcomes in long-term survivors of childhood leukemia, <strong>Hodgkin</strong>'s disease, and non-<strong>Hodgkin</strong>'s<br />

lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics 110, 42-52.<br />

135

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!